XML 51 R23.htm IDEA: XBRL DOCUMENT v3.2.0.727
ACQUISITION OF PERFORMANCE CHEMICALS & INGREDIENTS COMPANY (Tables)
6 Months Ended
Jun. 30, 2015
ACQUISITION OF PERFORMANCE CHEMICALS & INGREDIENTS COMPANY [Abstract]  
Estimated fair values of the assets acquired and liabilities assumed
The following table summarizes the estimated fair values of the assets acquired and liabilities assumed.

Cash and cash equivalents
 
$
2,635
 
Accounts receivable
  
25,674
 
Inventories
  
32,000
 
Property, plant and equipment
  
75,850
 
Customer relationships
  
130,300
 
Trade names
  
31,100
 
Developed technology
  
3,200
 
Other assets
  
3,955
 
Indemnification asset
  
1,650
 
Trade accounts payable
  
(10,427
)
Accrued expenses
  
(6,326
)
Bank debt
(75,550
)
Deferred income taxes
  
(75,760
)
Goodwill
  
355,391
 
Amount paid to shareholders
493,692
SensoryEffects bank debt paid on purchase date
  
75,550
 
Total amount paid on acquisition date
 
$
569,242
 
Acquisition of unaudited pro forma information
The following unaudited pro forma information has been prepared as if the Acquisition had occurred on January 1, 2013.

  
Three Months Ended
June 30,
  
Six Months Ended
June 30,
 
         
  
Net Sales
  
Net Earnings
  
Net Sales
  
Net Earnings
 
2015 SensoryEffects actual results included in the Company’s consolidated income statement
 
$
54,018
  
$
2,787
  
$
108,558
  
$
5,693
 
                 
2015 Supplemental pro forma combined financial information
 
$
134,773
  
$
14,916
  
$
279,635
  
$
30,088
 
                 
Basic earnings per share
     
$
0.48
      
$
0.97
 
Diluted earnings per share
     
$
0.47
      
$
0.95
 
                 
2014 SensoryEffects actual results included in the Company’s consolidated income statement from May 7, 2014 through June 30, 2014
 
$
36,395
  
$
(457
)
 
$
36,395
  
$
(457
)
                 
2014 Supplemental pro forma combined financial information
 
$
157,635
  
$
14,726
  
$
302,242
  
$
26,483
 
                 
Basic earnings per share
     
$
0.49
      
$
0.88
 
Diluted earnings per share
     
$
0.47
      
$
0.85